Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients

Author： Riess Jonathan W. Bhattacharya Nupur Blenman Kim R. M. Neal Joel W. Hwang Gloria Pultar Philippe San-Pedro Salcedo Melanie Engleman Edgar Lee Peter P. Malik Rajesh Wakelee Heather A.

Publisher： Informa Healthcare

ISSN： 0892-3973

Source： Immunopharmacology and Immunotoxicology, Vol.36, Iss.2, 2014-04, pp. : 182-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer

By Vansteenkiste Johan Canon Jean-Luc Riska Henrik Pirker Robert Peterson Patrick John William Mali Pekka Lahn Michael

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 263-269

Springer Publishing Company

Access to resources Recommend Favorite

Real-world chemotherapy treatment patterns in metastatic non–small cell lung cancer: Are patients undertreated?

By Sacher Adrian G. Le Lisa W. Lau Anthea Earle Craig C. Leighl Natasha B.

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2562-2569

Blackwell Publishing

Access to resources Recommend Favorite

Crizotinib: In Locally Advanced or Metastatic Non-Small Cell Lung Cancer

By Curran Monique P.

Drugs, Vol. 72, Iss. 1, 2012-01 ,pp. : 99-107

Adis International

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

By Trippoli S. Vaiani M. Lucioni C. Messori A.

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 855-863

Adis International

Access to resources Recommend Favorite